Literature DB >> 3030842

Inositol trisphosphate and tetrakisphosphate phosphomonoesterases of rat liver.

C J Kirk, R H Michell, J B Parry, S B Shears.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3030842     DOI： 10.1042/bst0150028

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN： 0300-5127            Impact factor:   5.407


× No keyword cloud information.
  5 in total

1.  Metabolism of D-myo-inositol 1,3,4,5-tetrakisphosphate by rat liver, including the synthesis of a novel isomer of myo-inositol tetrakisphosphate.

Authors:  S B Shears; J B Parry; E K Tang; R F Irvine; R H Michell; C J Kirk
Journal:  Biochem J       Date:  1987-08-15       Impact factor: 3.857

2.  Preferential localization of rat liver D-myo-inositol 1,4,5-trisphosphate/1,3,4,5-tetrakisphosphate 5-phosphatase in bile-canalicular plasma membrane and 'late' endosomal vesicles.

Authors:  S B Shears; W H Evans; C J Kirk; R H Michell
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

Review 3.  Metabolism of the inositol phosphates produced upon receptor activation.

Authors:  S B Shears
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

4.  Dephosphorylation of myo-inositol 1,4,5-trisphosphate and myo-inositol 1,3,4-triphosphate.

Authors:  S B Shears; D J Storey; A J Morris; A B Cubitt; J B Parry; R H Michell; C J Kirk
Journal:  Biochem J       Date:  1987-03-01       Impact factor: 3.857

5.  P2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells.

Authors:  W G Fang; F Pirnia; Y J Bang; C E Myers; J B Trepel
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.